BLOG / 🇺🇸 United States / broad market · · monthly

US Pre-Market SEC Filings Roundup — June 25, 2026

USA Before-Market Intelligence

By Gunpowder Editorial ·

35 high priority 15 medium priority 50 total filings analysed

Executive Summary

Overnight filings reveal a market bifurcated between aggressive insider selling at growth-stage tech firms and strategic capital deployment in energy and quantum sectors. The most significant development is GigCapital8's non-binding LOI to acquire Quantisimo Corp. at a ~$575M pre-money valuation, creating a pure-play quantum company, which carries high execution risk.

Insider selling is concentrated at Hinge Health ($19M+ by a 10% owner), Helios Technologies ($545K by a president), and Domo ($516K combined by C-suite), signaling potential management concern at elevated valuations or ahead of headwinds. Conversely, a $50M insider purchase at Kardigan and a $124K buy at Patrick Industries suggest strong conviction in value. On the corporate action front, LakeShore Biopharma's merger completion at a de minimis $0.066/share cash consideration represents a total loss for minority holders, while Enlight Renewable Energy's project-level guidance implies an 80%+ EBITA margin, a standout in the infrastructure space. The period-over-period data is limited in these filings, but the mix of insider activity and forward-looking statements points to a cautious tone in tech and biotech, with selective conviction in energy and industrial niches.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4 · Schedule 13D · 8-K · 425

Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from June 18, 2026.

Investment Signals (10)

  • Kardigan (BULLISH)

    A 10% owner purchased 3.125M shares at $16.00 for a total of $50M, representing a massive vote of confidence. The purchase price provides a clear floor for the stock and signals deep insider conviction in the company's value proposition.

  • A 10% owner (Insight Holdings Group) sold a combined 264,661 shares at ~$71.67, netting over $19M. This is a significant liquidation by a major backer, potentially signaling a peak in valuation or a lack of confidence in near-term upside.

  • The President of Hydraulics sold 6,027 shares at ~$90.42, netting $545K. This is a material sale by a key operational executive, which may indicate that the stock is fully valued or that near-term headwinds are anticipated.

  • Domo Inc. (BEARISH)

    The CEO, CFO, and CTO collectively sold 216,936 shares at $2.38, netting ~$516K. The coordinated selling by the entire C-suite at a low stock price is a major red flag, suggesting a lack of confidence in the company's turnaround or growth prospects.

  • The President - Marine bought 1,300 shares at $95.57 for ~$124K. This insider purchase in a cyclical industrial sector signals management's belief that the stock is undervalued and that the marine end-market is stabilizing or improving.

  • The company provided project-level guidance for its Total Complx project, projecting first full-year revenues of $250-260M and EBITA of $200-210M. This implies an 80%+ EBITA margin, a standout metric that suggests exceptional operational leverage and profitability in the renewable energy space.

  • Reported a 34.4% YoY rise in profit attributable to owners, reaching ¥1.58 trillion ($9.9B). This strong earnings growth, driven by higher ordinary income, signals robust underlying business performance despite a sharp 58.5% decline in trading income.

  • Received RBI approval to purchase up to 2% additional stake in its life insurance subsidiary, ICICI Prudential Life Insurance. This strategic move allows the bank to maintain majority control and signals confidence in the subsidiary's long-term value creation.

  • Apollo-affiliated entities sold 750,000 shares at $50.00 in a secondary offering, reducing their stake to 15.9%. While the sale is part of a planned offering, the large block sale by a major institutional holder can create overhang and pressure the stock.

  • Entered a non-binding LOI for a business combination valuing Quantisimo at ~$575M pre-money. The deal aims to create a pure-play quantum company, a high-growth thematic. The substantial equity rollover from existing holders is a positive signal, but the non-binding nature introduces significant execution risk.

Risk Flags (9)

  • The company completed a merger where ordinary shareholders receive only $0.066 per share in cash. This represents a near-total loss for minority shareholders and highlights the extreme risk of holding equity in companies undergoing distressed or squeeze-out mergers.

  • The CEO, CFO, and CTO all sold shares on the same day at $2.38. This coordinated sell-off by the entire executive team is a severe red flag, indicating a profound lack of confidence in the company's future and potential for further downside.

  • A 10% owner sold over $19M in stock in a single day. This level of selling by a sophisticated investor can signal a fundamental change in the company's outlook or a desire to exit the position, creating significant selling pressure.

  • The President of Hydraulics sold $545K in stock. This is a large, non-routine sale by a divisional head, which may signal that the hydraulics segment is facing headwinds or that the executive is de-risking personal holdings ahead of a downturn.

  • The Amended Omnibus Incentive Compensation Plan passed with only 60.1% of votes cast in favor. This high level of opposition (nearly 40% against) indicates significant shareholder discontent with the company's compensation practices, which could lead to governance issues or activist pressure.

  • The LOI for the Quantisimo deal is non-binding and subject to due diligence, financing, and regulatory approvals. There is no assurance a definitive agreement will be reached, creating binary risk for GIWWR shareholders.

  • The company terminated its Chief Technology Officer and Head of Reactor Development, Dr. Florent Heidet, effective June 22, 2026. The sudden departure of a key technical leader in a complex, capital-intensive industry raises concerns about project execution and pipeline stability.

  • Trading income fell sharply by 58.5% YoY. This significant decline in a key revenue stream, despite overall profit growth, highlights a vulnerability in the company's earnings mix and potential for future volatility.

  • Apollo / Hilton Grand Vacations Stake Reduction [MEDIUM RISK]

    Apollo's sale of 750,000 HGV shares reduces its influence and signals a potential exit strategy. This could lead to further overhang if Apollo continues to sell, and removes a potentially supportive large shareholder.

Opportunities (8)

  • The Total Complx project guidance implies an 80%+ EBITA margin, which is exceptional for the renewable energy sector. This suggests a highly differentiated asset or business model, presenting a significant alpha opportunity if the company can replicate this success.

  • The $50M insider purchase at $16.00 provides a strong valuation anchor. Investors can use this as a floor, with the potential for upside if the company executes on its business plan. The size of the purchase dwarfs typical insider buying.

  • The proposed merger with Quantisimo creates a rare, pure-play quantum computing company. If the deal closes, it could attract significant investor interest in a high-growth thematic area, offering substantial upside from current SPAC levels.

  • The President-Marine's purchase of $124K in stock at $95.57 is a bullish signal in a cyclical industry. It suggests that management sees the marine market bottoming and the stock as undervalued, offering a potential entry point for investors.

  • The RBI approval to increase its stake in ICICI Prudential Life Insurance allows the bank to capture more of the subsidiary's profits. This is a value-accretive move that could drive earnings growth and unlock shareholder value.

  • Despite a trading income collapse, core profit grew 34.4% YoY. The market may be overly focused on the volatile trading line, creating an opportunity for investors who see the strength in the underlying lending and fee-based businesses.

  • The company presented pivotal Phase II data for fanregratinib in a difficult-to-treat cancer (ICC) at a major medical congress. Positive data could be a significant catalyst, and the stock may not yet reflect the potential of this pipeline asset.

  • The President and COO was awarded 155,318 shares, a significant incentive grant. This aligns management's interests with shareholders and suggests the board is confident in the company's growth trajectory and the executive's ability to drive value.

Sector Themes (5)

  • Tech Insider Selling Wave

    A clear pattern of insider selling is emerging in the technology sector. Domo (CEO, CFO, CTO), Hinge Health (10% owner), and Helios Technologies (President) all saw significant insider sales. This suggests a broad-based lack of conviction among tech insiders, possibly due to valuation concerns or a cautious outlook on growth. Investors should scrutinize tech holdings for similar patterns.

  • Energy & Infrastructure Conviction

    In contrast to tech, there is strong insider and corporate conviction in energy and infrastructure. The $50M insider purchase at Kardigan, the project-level guidance from Enlight Renewable Energy (80%+ margins), and the insider buy at Patrick Industries all point to a bullish outlook in these sectors, driven by project visibility and favorable demand trends.

  • SPAC Activity Returns with Quantum Theme

    The GigCapital8 / Quantisimo LOI marks a notable SPAC transaction in the quantum computing space. This could signal a revival in SPAC activity, particularly for high-tech, thematic deals. The substantial equity rollover is a positive structural feature, but the non-binding nature highlights the inherent risk.

  • Biotech & Pharma: Binary Events and Distress

    The filings show a stark contrast in biotech. HUTCHMED's pivotal data readout represents a high-upside catalyst, while LakeShore Biopharma's merger at $0.066/share is a total loss event. This bifurcation underscores the binary nature of biotech investing, where due diligence on capital structure and deal terms is critical.

  • Financials: Strong Core, Volatile Periphery

    Sumitomo Mitsui's results show a strong core business (34.4% profit growth) but a volatile trading book (58.5% decline). This theme is common across large financial institutions, where strong net interest income can be obscured by mark-to-market losses in trading or investment portfolios. The opportunity lies in identifying banks with stable, fee-based income streams.

Watch List (8)

  • Watch for a definitive agreement, financing details, and shareholder vote. The non-binding LOI has a high chance of failure, but success would create a unique quantum pure-play. Key dates: Negotiation of definitive agreement.

  • Monitor for further insider sales or any guidance changes. The coordinated C-suite sell-off is a major red flag. Watch for the next earnings call for commentary on business trends. Next earnings: likely late August/early September 2026.

  • Monitor for continued selling by Insight Holdings Group. If the selling persists, it could indicate a full exit and create persistent downward pressure. Watch for any Form 4 filings showing further disposals.

  • Watch for project financing announcements, construction milestones, and updates on the revenue/EBITA guidance. The 80%+ margin projection is a key metric to track. Next catalyst: Project financial close or construction start.

  • Monitor the delisting process from OTC Pink and the final cash-out process for shareholders. This serves as a case study for risks in small-cap biotech mergers. Key event: Effective delisting date.

  • Watch for the appointment of a permanent CTO and Head of Reactor Development. The longer the interim period, the higher the risk to project timelines. Key event: Announcement of a permanent replacement.

  • The AGM is scheduled for July 15, 2026. Watch for any shareholder proposals, management commentary on the business outlook, or strategic updates that could impact the stock. Key date: July 15, 2026.

  • The 19% broker non-vote on director elections is notable. Watch for any activist activity or shareholder proposals at the next meeting, as it signals a portion of the shareholder base is disengaged or dissatisfied. Key event: Next annual meeting in 2027.

Filing Analyses (50)
PATRICK INDUSTRIES INC 4 positive materiality 3/10

24-06-2026

President - Marine Petkovich Jacob R bought 1,300 Common Stock at $95.57 (~$124K). Petkovich Jacob R holds 46,290 shares after the transaction.

  • · President - Marine Petkovich Jacob R bought 1,300 Common Stock at $95.57 (~$124K)
Joint Stock Co Kaspi.kz 4 negative materiality 5/10

24-06-2026

Director Kim Vyacheslav sold 14,940 American Depositary Shares, no par value at $85.79 (~$1.28M). 8 transactions reported in total. Trades executed under a Rule 10b5-1 plan.

  • · Director Kim Vyacheslav sold 3,293 American Depositary Shares, no par value at $82.55 (~$272K)
  • · Director Kim Vyacheslav sold 8,008 American Depositary Shares, no par value at $84.87 (~$680K)
  • · Director Kim Vyacheslav sold 11,102 American Depositary Shares, no par value at $85.43 (~$948K)
  • · Director Kim Vyacheslav sold 14,637 American Depositary Shares, no par value at $83.45 (~$1.22M)
  • · Director Kim Vyacheslav sold 162 American Depositary Shares, no par value at $84.14 (~$13.6K)
  • · Director Kim Vyacheslav sold 14,940 American Depositary Shares, no par value at $85.79 (~$1.28M)
  • · Director Kim Vyacheslav sold 5,917 American Depositary Shares, no par value at $87.00 (~$515K)
  • · Director Kim Vyacheslav sold 3,912 American Depositary Shares, no par value at $87.57 (~$343K)
Cardinal Infrastructure Group Inc. S-1MEF neutral materiality 5/10

24-06-2026

Cardinal Infrastructure Group Inc. filed an S-1MEF registration statement to register an additional 287,500 shares of Class A common stock (including 37,500 shares for underwriters' option) under Rule 462(b), representing no more than 20% of the maximum aggregate offering price from the prior S-1. The filing incorporates by reference the prior registration statement (File No. 333-296958) and became effective upon filing on June 24, 2026.

  • · The filing is made under Rule 462(b) to register additional securities for an offering pursuant to the earlier effective registration statement (File No. 333-296958).
  • · The company's state of incorporation is Delaware, with fiscal year end December 31.
  • · The company was formerly named Civil Infrastructure Group Inc. and changed its name on August 5, 2025.
  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
  • · The filing fee is to be paid by wire transfer to the Commission's account at Truist Bank by June 25, 2026.
  • · The opinion of Willkie Farr & Gallagher LLP and consents of Grant Thornton LLP and Warren Averett, LLC are filed as exhibits.
Hilton Grand Vacations Inc. SC 13D/A neutral materiality 6/10

24-06-2026

Apollo-affiliated entities filed a Schedule 13D/A disclosing that as of June 22, 2026, they sold an aggregate of 750,000 shares of Hilton Grand Vacations Inc. (HGV) common stock at $50.00 per share in connection with underwriters exercising their option in a public offering. Following the sale, the Apollo group's aggregate beneficial ownership stands at 15.9% of HGV's outstanding common stock (based on 78,515,453 shares outstanding as of June 4, 2026). The filing also notes that certain entities and individuals disclaim beneficial ownership of shares held by Dakota Co-Invest and Dakota Holdings Borrower.

  • · The sale was part of underwriters exercising their option to purchase an additional 750,000 shares in a previously reported public offering.
  • · Dakota Co-Invest sold 191,154 shares and Dakota Holdings Borrower sold 558,846 shares of the total 750,000.
  • · The filing is Amendment No. 4 to the original Schedule 13D filed on August 11, 2021.
  • · Apollo entities and individuals disclaim beneficial ownership of shares held by Dakota Co-Invest and Dakota Holdings Borrower, except for pecuniary interest.
Moleculin Biotech, Inc. 4 neutral materiality 3/10

24-06-2026

Chief Science Officer PICKER DONALD H had withheld for taxes 21 Common Stock at $3.12 (~$65.5). 6 transactions reported in total. PICKER DONALD H holds 753 shares after the transaction.

  • · Chief Science Officer PICKER DONALD H exercised/converted 44 Common Stock
  • · Chief Science Officer PICKER DONALD H had withheld for taxes 13 Common Stock at $2.88 (~$37.4)
  • · Chief Science Officer PICKER DONALD H exercised/converted 71 Common Stock
  • · Chief Science Officer PICKER DONALD H had withheld for taxes 21 Common Stock at $3.12 (~$65.5)
  • · Chief Science Officer PICKER DONALD H exercised/converted 44 Restricted Stock Units
  • · Chief Science Officer PICKER DONALD H exercised/converted 71 Restricted Stock Units
Moleculin Biotech, Inc. 4 neutral materiality 4/10

24-06-2026

CEO and President KLEMP WALTER V had withheld for taxes 88 Common Stock at $3.12 (~$275). 6 transactions reported in total. KLEMP WALTER V holds 31,007 shares after the transaction.

  • · CEO and President KLEMP WALTER V exercised/converted 150 Common Stock
  • · CEO and President KLEMP WALTER V had withheld for taxes 37 Common Stock at $2.88 (~$107)
  • · CEO and President KLEMP WALTER V exercised/converted 360 Common Stock
  • · CEO and President KLEMP WALTER V had withheld for taxes 88 Common Stock at $3.12 (~$275)
  • · CEO and President KLEMP WALTER V exercised/converted 150 Restricted Stock Units
  • · CEO and President KLEMP WALTER V exercised/converted 360 Restricted Stock Units
Hilton Grand Vacations Inc. 4 neutral materiality 5/10

24-06-2026

10% owner Apollo Principal Holdings A GP, Ltd. disposed of 750,000 Common Stock at $50.00 (~$37.5M). Apollo Principal Holdings A GP, Ltd. holds 12,495,825 shares after the transaction.

  • · 10% owner Apollo Principal Holdings A GP, Ltd. disposed of 750,000 Common Stock at $50.00 (~$37.5M)
Moleculin Biotech, Inc. 4 neutral materiality 3/10

24-06-2026

Chief Financial Officer Foster Jonathan P. had withheld for taxes 41 Common Stock at $3.12 (~$128). 6 transactions reported in total. Foster Jonathan P. holds 12,340 shares after the transaction.

  • · Chief Financial Officer Foster Jonathan P. exercised/converted 109 Common Stock
  • · Chief Financial Officer Foster Jonathan P. had withheld for taxes 31 Common Stock at $2.88 (~$89.3)
  • · Chief Financial Officer Foster Jonathan P. exercised/converted 174 Common Stock
  • · Chief Financial Officer Foster Jonathan P. had withheld for taxes 41 Common Stock at $3.12 (~$128)
  • · Chief Financial Officer Foster Jonathan P. exercised/converted 109 Restricted Stock Units
  • · Chief Financial Officer Foster Jonathan P. exercised/converted 174 Restricted Stock Units
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director Glaser Rachel C was awarded 8,262 Common Stock, par value $0.01 per share. Glaser Rachel C holds 12,419 shares after the transaction.

  • · Director Glaser Rachel C was awarded 8,262 Common Stock, par value $0.01 per share
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director BERISFORD JOHN L was awarded 8,262 Common Stock, par value $0.01 per share. BERISFORD JOHN L holds 11,235 shares after the transaction.

  • · Director BERISFORD JOHN L was awarded 8,262 Common Stock, par value $0.01 per share
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director Hill John W was awarded 8,262 Common Stock, par value $0.01 per share. Hill John W holds 26,493 shares after the transaction.

  • · Director Hill John W was awarded 8,262 Common Stock, par value $0.01 per share
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director Brunner Angelique G. was awarded 8,262 Common Stock, par value $0.01 per share. Brunner Angelique G. holds 18,428 shares after the transaction.

  • · Director Brunner Angelique G. was awarded 8,262 Common Stock, par value $0.01 per share
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director Musslewhite Robert W was awarded 8,262 Common Stock, par value $0.01 per share. Musslewhite Robert W holds 26,539 shares after the transaction.

  • · Director Musslewhite Robert W was awarded 8,262 Common Stock, par value $0.01 per share
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director Sams Louise S was awarded 8,262 Common Stock, par value $0.01 per share. Sams Louise S holds 28,671 shares after the transaction.

  • · Director Sams Louise S was awarded 8,262 Common Stock, par value $0.01 per share
COSTAR GROUP, INC. 4 neutral materiality 4/10

24-06-2026

Director McCarthy Christine M was awarded 8,262 Common Stock, par value $0.01 per share. McCarthy Christine M holds 11,585 shares after the transaction.

  • · Director McCarthy Christine M was awarded 8,262 Common Stock, par value $0.01 per share
HECLA MINING CO/DE/ 4 neutral materiality 4/10

24-06-2026

VP - Sustainability Malone Patrick Shay was awarded 19,548 Common Stock at $15.98 (~$312K). 4 transactions reported in total. Malone Patrick Shay holds 2,307 shares after the transaction.

  • · VP - Sustainability Malone Patrick Shay had withheld for taxes 17,846 Common Stock at $15.98 (~$285K)
  • · VP - Sustainability Malone Patrick Shay was awarded 19,548 Common Stock at $15.98 (~$312K)
  • · VP - Sustainability Malone Patrick Shay acquired 2,307 Common Stock
  • · VP - Sustainability Malone Patrick Shay was awarded 19,548 Common Stock
Kardigan, Inc. 4 positive materiality 6/10

24-06-2026

10% owner HRTG GPE, LLC bought 3,125,000 Common Stock at $16.00 (~$50M). HRTG GPE, LLC holds 14,866,868 shares after the transaction.

  • · 10% owner HRTG GPE, LLC bought 3,125,000 Common Stock at $16.00 (~$50M)
HECLA MINING CO/DE/ 4 neutral materiality 5/10

24-06-2026

Vice President - Exploration Allen Kurt was awarded 19,548 Common Stock at $15.98 (~$312K). 4 transactions reported in total. Allen Kurt holds 28,117 shares after the transaction.

  • · Vice President - Exploration Allen Kurt had withheld for taxes 14,309 Common Stock at $15.98 (~$229K)
  • · Vice President - Exploration Allen Kurt was awarded 19,548 Common Stock at $15.98 (~$312K)
  • · Vice President - Exploration Allen Kurt acquired 28,117 Common Stock
  • · Vice President - Exploration Allen Kurt was awarded 19,548 Performance rights
Lifeloc Technologies, Inc 4 positive materiality 3/10

24-06-2026

Director Kornelsen Michael bought 100 Common Stock at $2.50 (~$250). Kornelsen Michael holds 1,100 shares after the transaction.

  • · Director Kornelsen Michael bought 100 Common Stock at $2.50 (~$250)
DPC Holdings Ltd S-1MEF neutral materiality 4/10

24-06-2026

DPC Holdings Limited filed an S-1MEF registration statement with the SEC on June 24, 2026, to register an additional 5,204,040 ordinary shares under Rule 462(b), representing no more than 20% of the maximum aggregate offering price from its prior S-1 (File No. 333-296215). The company intends to change its legal status from a Jersey private company to a Jersey public limited company and rename to DPC Holdings PLC prior to consummating the offering. No financial performance data is provided in this filing.

  • · The filing is made under Rule 462(b) and incorporates by reference the prior S-1 (File No. 333-296215) filed May 26, 2026, which was declared effective on June 24, 2026.
  • · The company is an emerging growth company and a non-accelerated filer.
  • · The filing fee is to be paid by wire transfer no later than June 25, 2026.
  • · The company's principal executive offices are at 2nd Floor, Donington Court, Pegasus Business Park, Herald Way, Derby, DE742UZ, United Kingdom.
  • · The agent for service in the U.S. is Corporation Service Company, 241 Little Falls Drive, Wilmington, DE 19808.
Reservoir Media, Inc. 4 neutral materiality 3/10

24-06-2026

Director Field Ezra S. was awarded 1,231 Common stock, $0.0001 par value at $10.15 (~$12.5K). Field Ezra S. holds 175,243 shares after the transaction.

  • · Director Field Ezra S. was awarded 1,231 Common stock, $0.0001 par value at $10.15 (~$12.5K)
DOMO, INC. 4 negative materiality 5/10

24-06-2026

Chief Financial Officer Crane Tod sold 68,483 Class B Common Stock at $2.38 (~$163K). Crane Tod holds 276,809 shares after the transaction.

  • · Chief Financial Officer Crane Tod sold 68,483 Class B Common Stock at $2.38 (~$163K)
Reservoir Media, Inc. 4 neutral materiality 3/10

24-06-2026

Director Rothstein Adam was awarded 492 Common stock, $0.0001 par value at $10.15 (~$4.99K). Rothstein Adam holds 79,376 shares after the transaction.

  • · Director Rothstein Adam was awarded 492 Common stock, $0.0001 par value at $10.15 (~$4.99K)
DOMO, INC. 4 negative materiality 5/10

24-06-2026

Founder and CEO James Joshua G sold 96,088 Class B Common Stock at $2.38 (~$228K). James Joshua G holds 1,638,873 shares after the transaction.

  • · Founder and CEO James Joshua G sold 96,088 Class B Common Stock at $2.38 (~$228K)
HELIOS TECHNOLOGIES, INC. 4 negative materiality 7/10

24-06-2026

President of Hydraulics, FCT Arduini Matteo sold 6,027 Common Stock at $90.42 (~$545K). 8 transactions reported in total. Arduini Matteo holds 11,317 shares after the transaction.

  • · President of Hydraulics, FCT Arduini Matteo sold 4,000 Common Stock at $89.93 (~$360K)
  • · President of Hydraulics, FCT Arduini Matteo exercised/converted 874 Common Stock at $39.75 (~$34.7K)
  • · President of Hydraulics, FCT Arduini Matteo exercised/converted 1,153 Common Stock at $55.03 (~$63.4K)
  • · President of Hydraulics, FCT Arduini Matteo exercised/converted 4,000 Common Stock at $50.60 (~$202K)
  • · President of Hydraulics, FCT Arduini Matteo sold 6,027 Common Stock at $90.42 (~$545K)
  • · President of Hydraulics, FCT Arduini Matteo exercised/converted 874 Stock Options (right to buy)
  • · President of Hydraulics, FCT Arduini Matteo exercised/converted 1,153 Stock Options (right to buy)
  • · President of Hydraulics, FCT Arduini Matteo exercised/converted 4,000 Stock Options (right to buy)
Hinge Health, Inc. 4 negative materiality 7/10

24-06-2026

10% owner Insight Holdings Group, LLC sold 119,244 Class A Common Stock at $71.67 (~$8.55M). Trades executed under a Rule 10b5-1 plan.

  • · 10% owner Insight Holdings Group, LLC sold 119,244 Class A Common Stock at $71.67 (~$8.55M)
  • · 10% owner Insight Holdings Group, LLC sold 23,067 Class A Common Stock at $71.67 (~$1.65M)
Hinge Health, Inc. 4 negative materiality 8/10

24-06-2026

10% owner Insight Holdings Group, LLC sold 145,417 Class A Common Stock at $71.67 (~$10.4M). 18 transactions reported in total. Insight Holdings Group, LLC holds 23,067 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

  • · 10% owner Insight Holdings Group, LLC sold 60,888 Class A Common Stock at $70.75 (~$4.31M)
  • · 10% owner Insight Holdings Group, LLC sold 1,449 Class A Common Stock at $70.75 (~$103K)
  • · 10% owner Insight Holdings Group, LLC sold 49,929 Class A Common Stock at $70.75 (~$3.53M)
  • · 10% owner Insight Holdings Group, LLC sold 9,658 Class A Common Stock at $70.75 (~$683K)
  • · 10% owner Insight Holdings Group, LLC sold 51,176 Class A Common Stock at $71.20 (~$3.64M)
  • · 10% owner Insight Holdings Group, LLC sold 1,217 Class A Common Stock at $71.20 (~$86.6K)
  • · 10% owner Insight Holdings Group, LLC sold 41,964 Class A Common Stock at $71.20 (~$2.99M)
  • · 10% owner Insight Holdings Group, LLC sold 8,118 Class A Common Stock at $71.20 (~$578K)
Reservoir Media, Inc. 4 neutral materiality 4/10

24-06-2026

President and COO Lafargue Rell Q. Jr. was awarded 155,318 Common stock, $0.0001 par value. Lafargue Rell Q. Jr. holds 611,254 shares after the transaction.

  • · President and COO Lafargue Rell Q. Jr. was awarded 155,318 Common stock, $0.0001 par value
DOMO, INC. 4 negative materiality 3/10

24-06-2026

CTO & EVP of Product Thayne Daren sold 52,365 Class B Common Stock at $2.38 (~$125K). Thayne Daren holds 498,051 shares after the transaction.

  • · CTO & EVP of Product Thayne Daren sold 52,365 Class B Common Stock at $2.38 (~$125K)
Reservoir Media, Inc. 4 neutral materiality 4/10

24-06-2026

Chief Financial Officer Heindlmeyer James A was awarded 18,567 Common stock, $0.0001 par value. Heindlmeyer James A holds 89,578 shares after the transaction.

  • · Chief Financial Officer Heindlmeyer James A was awarded 18,567 Common stock, $0.0001 par value
Fortress Biotech, Inc. 4 neutral materiality 4/10

24-06-2026

Chief Financial Officer Jin David was awarded 400,000 Common Stock, par value $0.001. Jin David holds 1,651,571 shares after the transaction.

  • · Chief Financial Officer Jin David was awarded 400,000 Common Stock, par value $0.001
TOYOTA MOTOR CREDIT CORP 8-K neutral materiality 3/10

25-06-2026

Toyota Motor Credit Corporation (TMCC) announced the resignation of Brittany Baird as principal accounting officer effective June 29, 2026, due to her appointment as CFO of Toyota Financial Savings Bank. Carlos Adrian Gruebler has been appointed as the new principal accounting officer, effective the same date, having served as interim chief accounting officer since February 2026.

  • · Effective date of changes: June 29, 2026.
  • · Mr. Gruebler has served as Interim Chief Accounting Officer since February 2026.
  • · Additional biographical information for Mr. Gruebler is available in the Annual Report on Form 10-K for fiscal year ended March 31, 2026, filed on June 2, 2026.
Cordyceps Sunshine Biotech Holdings Co., Ltd. 6-K neutral materiality 3/10

25-06-2026

Cordyceps Sunshine Biotech Holdings Co., Ltd. disclosed in a 6-K filing that commercial revenues from its Antcin A platform will be split equally (50/50) between two unnamed parties unless otherwise agreed in writing. The filing provides no additional context on the parties, revenue projections, or timelines, making the financial impact unclear.

  • · The revenue-sharing arrangement is subject to change by mutual written agreement of the parties.
  • · No revenue figures, launch dates, or commercialization milestones for the Antcin A platform were disclosed.
LakeShore Biopharma Co., Ltd. SC 13D/A negative materiality 10/10

25-06-2026

LakeShore Biopharma Co., Ltd. completed its merger with a parent company on June 24, 2026, becoming a wholly owned subsidiary. Shareholders approved the transaction on June 19, 2026, and ordinary shareholders receive $0.066 per share cash consideration. As a result, all reporting persons ceased to be beneficial owners of more than 5% of the company's shares, and the company's securities will be delisted from OTC Pink, with trading symbols to be removed.

  • · The merger was approved by shareholders at an extraordinary general meeting on June 19, 2026.
  • · The Plan of Merger was filed with the Cayman Islands Registrar of Companies and became effective on June 24, 2026.
  • · Excluded shares and dissenting shares were cancelled without any payment.
  • · 2020 Plan options and RSUs that were unvested became fully vested at the closing and were cancelled for cash consideration equal to the excess of $0.066 per share over the exercise price (for options) or $0.066 per share (for RSUs).
  • · 2024 Plan options and RSUs were assumed by the Parent under a new equity incentive plan, with terms adjusted by an exchange ratio based on the per share consideration and fair market value of parent shares.
  • · The company intends to file a Form 15 to suspend its SEC reporting obligations.
  • · No transactions in ordinary shares were effected by reporting persons during the past 60 days.
HUTCHMED (China) Ltd 6-K neutral materiality 5/10

25-06-2026

HUTCHMED announced pivotal Phase II data for fanregratinib in intrahepatic cholangiocarcinoma (ICC) presented at ESMO Gastrointestinal Cancers Congress 2026. The data highlights the drug's potential in a difficult-to-treat cancer, but no specific efficacy or safety figures are disclosed in the filing.

  • · Data presented at ESMO Gastrointestinal Cancers Congress 2026
  • · Fanregratinib targets intrahepatic cholangiocarcinoma, a rare and aggressive bile duct cancer
ORIX CORP 6-K positive materiality 3/10

25-06-2026

ORIX CORP held its Annual General Meeting where all 12 proposals were approved by shareholders. Proposal 1 received 99.87% approval, while Proposal 2 received a lower but still passing 77.23% approval. All director nominees were elected with approval rates ranging from 98.95% to 99.61%.

  • · Proposal 2 received 1,999,722 disapprovals, the highest among all proposals.
  • · Hiroshi Watanabe had 2,505 abstentions, the only nominee with abstentions.
  • · Chikatomo Hodo had 6,882 abstentions, the highest abstention count among all proposals.
  • · All director nominees were elected with approval rates above 98.9%.
NIP Group Inc. 6-K neutral materiality 3/10

25-06-2026

NIP Group Inc. published its 2025 Sustainability Report, highlighting its commitment to driving global growth and cultural inclusion in digital entertainment. The report was announced via a press release on June 25, 2026, and signed by co-CEOs Mario Yau Kwan Ho and Hicham Chahine.

  • · The filing is a Form 6-K for the month of June 2026.
  • · Commission File Number: 001-42160.
  • · Principal executive offices are located at Rosenlundsgatan 31, 11 863 Stockholm, Sweden.
  • · The registrant files annual reports under Form 20-F.
WIPRO LTD 6-K neutral materiality 1/10

25-06-2026

Wipro Limited filed a Form 6-K with the SEC on June 25, 2026, providing details regarding its upcoming Annual General Meeting (AGM) scheduled for July 15, 2026, to be held via video conferencing. The company has notified stock exchanges in India and the NYSE, published newspaper advertisements, and sent the Notice of AGM with e-voting instructions to shareholders by email on June 22, 2026. No financial results or performance metrics were disclosed in this filing.

  • · AGM date: July 15, 2026 at 9:00 AM IST
  • · AGM to be conducted via video conferencing
  • · Notice of AGM and e-voting instructions sent by email on June 22, 2026
  • · Newspaper advertisements placed on June 17 and June 23, 2026
  • · Notice of AGM available on Wipro's investor website
SUMITOMO MITSUI FINANCIAL GROUP, INC. 6-K mixed materiality 8/10

25-06-2026

Sumitomo Mitsui Financial Group reported a strong fiscal year ending March 31, 2026, with profit attributable to owners of parent rising 34.4% YoY to ¥1,582,973 million ($9.9B), driven by higher ordinary income and lower trading losses. Total assets grew 7.3% to ¥328,511,145 million ($2.05T), while deposits increased 8.3%. However, trading income fell sharply by 58.5% YoY, and net deferred losses on hedges widened to ¥300,715 million, indicating mixed performance in certain segments.

  • · Cash and due from banks decreased 2.5% YoY to ¥73,696,930 million.
  • · Securities decreased 1.9% YoY to ¥39,974,120 million.
  • · Foreign exchanges assets decreased 25.1% YoY to ¥2,030,821 million.
  • · Negotiable certificates of deposit decreased 8.8% YoY to ¥15,667,132 million.
  • · Borrowed money decreased 17.5% YoY to ¥9,370,996 million.
  • · Net deferred losses on hedges widened from ¥168,604 million to ¥300,715 million.
  • · Other extraordinary losses of ¥47,480 million were recorded in FY2026 (none in FY2025).
  • · Deferred tax liabilities increased 46.9% YoY to ¥619,716 million.
  • · Reserve for reimbursement of deposits increased 542.5% YoY to ¥35,806 million.
  • · Retained earnings grew 7.0% to ¥8,871,065 million.
  • · Treasury stock increased (more negative) by 26.8% to ¥48,851 million.
  • · Capital surplus decreased 4.7% to ¥582,909 million.
  • · Cash dividends paid increased 31.1% to ¥540,292 million.
  • · Decrease due to a decrease in equity method affiliates of ¥224,699 million was recorded in FY2026.
ICICI BANK LTD 6-K positive materiality 6/10

25-06-2026

ICICI Bank received RBI approval on June 24, 2026 to purchase up to 2% additional shareholding in its subsidiary ICICI Prudential Life Insurance Company, enabling the Bank to maintain its stake above 50%. The approval is subject to compliance with certain conditions. This follows the Bank's initial disclosure on February 28, 2026 regarding the proposed acquisition.

  • · RBI approval was granted via letter dated June 24, 2026.
  • · The Bank had initially disclosed the plan to purchase up to 2% additional shareholding on February 28, 2026.
  • · The approval is subject to compliance with certain conditions (not specified in the filing).
GIGAMEDIA Ltd 6-K neutral materiality 3/10

25-06-2026

GigaMedia Limited held its Annual General Meeting of Shareholders in June 2026, where shareholders voted on and approved all proposed resolutions. The company filed the results via Form 6-K with the SEC on June 25, 2026. No specific financial results or operational updates were disclosed in this filing.

  • · The filing is a Form 6-K submitted to the SEC on June 25, 2026.
  • · The company's Annual General Meeting was held in June 2026.
  • · All proposed resolutions at the AGM were approved by shareholders.
OMEROS CORP 8-K mixed materiality 5/10

25-06-2026

Omeros Corporation held its 2026 Annual Meeting on June 18, 2026, with 80.04% of shares represented. Shareholders elected three Class II directors and approved the advisory resolution on executive compensation and the ratification of Ernst & Young as auditor. However, the Amended and Restated Omnibus Incentive Compensation Plan passed with only 60.1% of votes cast in favor, indicating significant shareholder opposition.

  • · Thomas J. Cable received 20,787,774 votes for (64.7% of votes cast excluding broker non-votes) and 10,531,585 against.
  • · Peter A. Demopulos received 25,314,641 votes for (79.7%) and 6,063,216 against.
  • · Diana T. Perkinson received 22,939,756 votes for (72.3%) and 8,295,563 against.
  • · Advisory resolution on executive compensation passed with 24,384,445 for (76.8%) and 6,856,592 against.
  • · Ratification of Ernst & Young as auditor passed overwhelmingly with 53,083,043 for (91.5%) and 4,423,648 against.
  • · Broker non-votes were 26,262,042 on all proposals except auditor ratification (which had none).
Enlight Renewable Energy Ltd. 6-K positive materiality 6/10

25-06-2026

Enlight Renewable Energy Ltd. filed a 6-K with projections for its Total Complx project: investment net of tax equity between $1,450–1,520 million, projected first full-year revenues of $250–260 million, and projected first full-year EBITA of $200–210 million. The projections indicate strong anticipated margins (over 80% EBITA margin), though the figures are preliminary and subject to change.

  • · The filing is a Form 6-K, dated June 25, 2026.
  • · All figures are for 'Total Complx' project and are presented as ranges.
  • · EBITA is projected at $200–210 million against revenues of $250–260 million, implying high operating leverage.
  • · No prior-year comparable data is provided, so period-over-period trend analysis is not possible.
  • · The filing does not include any update on balance sheet, cash flow, or other operational metrics.
SILICOM LTD. F-3 neutral materiality 3/10

25-06-2026

SILICOM LTD. filed an F-3 shelf registration statement on June 25, 2026, allowing it to offer and sell ordinary shares from time to time. The company has broad discretion over the use of proceeds, which will be used for general corporate purposes including working capital, capital expenditures, and acquisitions. As of the filing date, the company had 5,747,611 ordinary shares issued and outstanding, with an additional 2,087,132 shares held as treasury shares.

  • · The ordinary shares are listed on the Nasdaq Global Select Market under the symbol 'SILC'.
  • · Ordinary shares have a par value of NIS 0.01 each.
  • · The company was incorporated in Israel in 1987 and operates under Israeli law.
  • · Shareholders have one vote per share, with no cumulative voting rights for directors.
  • · A quorum for a general meeting requires at least two shareholders holding at least 33 1/3% of voting rights.
  • · The filing includes detailed descriptions of Israeli tender offer and merger regulations.
Aeva Technologies, Inc. 8-K positive materiality 3/10

25-06-2026

Aeva Technologies, Inc. held its 2026 Annual Meeting of Stockholders on June 18, 2026, where shareholders elected Class II directors Hrach Simonian and Stephen Zadesky to the board, and ratified the appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2026. Both director nominees received strong support, though Simonian had a higher withhold vote count (3,523,150) compared to Zadesky (2,387,049). The auditor ratification passed overwhelmingly with 43,599,661 votes in favor and only 63,879 against.

  • · The annual meeting was held on June 18, 2026.
  • · The proxy statement was filed on April 29, 2026.
  • · Broker non-votes for the director election totaled 14,098,492 for each nominee.
  • · The auditor ratification proposal had no broker non-votes because it is a routine matter.
GigCapital8 Corp. 425 positive materiality 9/10

25-06-2026

GigCapital8 Corp. (Nasdaq: GIWWR) announced on June 25, 2026 that it has entered into a non-binding letter of intent (LOI) for a business combination with Quantisimo Corp., a special purpose vehicle jointly established by WISeKey International Holding Ltd. and its subsidiary SEALSQ Corp. (Nasdaq: LAES), to create a Trusted Quantum Pure-Play public company. The pre-money enterprise value of Quantisimo is approximately $575 million, and the combined entity is expected to list on a national stock exchange. However, the LOI is non-binding, and there can be no assurance that a definitive agreement will be reached or that the transaction will be consummated on the proposed terms, within the anticipated timeframe, or at all.

  • · Quantisimo was founded by WISeKey and SEALSQ to provide direct exposure to the quantum economy.
  • · Former equityholders of Quantisimo are expected to own a majority of the combined company's equity.
  • · Completion requires shareholder approval, regulatory review, and secured financing.
  • · The LOI is non-binding, and no definitive agreement has been signed yet.
GigCapital8 Corp. 8-K neutral materiality 6/10

25-06-2026

GigCapital8 Corp. (GIWWR) announced it has entered into a non-binding letter of intent for a business combination with Quantisimo Corp., a special purpose vehicle jointly established by WISeKey and SEALSQ to create a quantum pure-play platform. The pre-money enterprise value of Quantisimo is approximately $575 million. The transaction is subject to negotiation of definitive agreements, due diligence, and regulatory approvals, with no assurance of consummation.

  • · The combined public company is expected to be listed on a national stock exchange with Quantisimo's existing equityholders owning a majority of the equity.
  • · A substantial rollover of equity by Quantisimo's existing equityholders is expected.
  • · The transaction is subject to completion of due diligence, stock exchange and regulatory review, approval by GigCapital8 shareholders, and securing financing arrangements.
Addex Therapeutics Ltd. 6-K neutral materiality 5/10

25-06-2026

Addex Therapeutics Ltd filed a Form 6-K with the SEC on June 25, 2026, including unaudited interim condensed consolidated financial statements, management's discussion and analysis, and a press release. The filing incorporates forward-looking statements and risk factors, referencing the company's Annual Report on Form 20-F for the year ended December 31, 2025. No specific financial figures or performance metrics are disclosed in the filing text itself.

  • · The filing incorporates by reference registration statements on Form F-3 (No. 333-291644) and Form S-8 (No. 333-255124 and No. 333-272515).
  • · The Annual Report on Form 20-F for the year ended December 31, 2025 was filed on May 15, 2026.
  • · Exhibits include unaudited interim condensed consolidated financial statements (Exhibit 99.1), MD&A (Exhibit 99.2), and a press release (Exhibit 99.3).
Nano Nuclear Energy Inc. 8-K neutral materiality 5/10

25-06-2026

Nano Nuclear Energy Inc. terminated Dr. Florent Heidet as Chief Technology Officer and Head of Reactor Development effective June 22, 2026, with the termination unanimously approved by the Board. CEO James Walker has been appointed as Interim Head of Reactor Development. No financial terms or severance details were disclosed.

  • · Termination was effective June 22, 2026, and included termination of Dr. Heidet's employment agreement dated March 6, 2025 (except for survival provisions).
  • · No arrangements or understandings exist between James Walker and any other person regarding his appointment as Interim Head of Reactor Development.
  • · No family relationships or reportable transactions under Item 404(a) of Regulation S-K involving James Walker.
RH 8-K positive materiality 4/10

25-06-2026

RH held its annual meeting on June 18, 2026, where shareholders elected three Class II directors (Hilary Krane, Katie Mitic, and Ali Rowghani) and approved, on a non-binding advisory basis, executive compensation and a one-year frequency for future say-on-pay votes. The ratification of PricewaterhouseCoopers as independent auditor for FY ending January 30, 2027, was also passed with overwhelming support (over 99% of votes cast), but broker non-votes on the director elections and advisory compensation proposals represented roughly 19% of total shares outstanding, indicating a notable portion of shares were not voted on those items.

Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Pre-Market SEC Filings Roundup

🇺🇸 More from United States

View all →